Commercial Credit Report for Organika AO

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Organika AO is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Organika AO
shosse Kuznetskoye, 3
Phone: +7 3843994222p:+7 3843994222	NOVOKUZNETSK, 654034 Russian Federation	Ticker: orgnorgn

On March 4, 2022, CreditRiskMonitor.com, Inc. suppressed the FRISK® score of all publicly listed Russian and Ukrainian-based companies trading domestically due to the closure of their respective stock markets. The halt of trading in a counterparty’s securities is never a positive signal for creditors or suppliers, but especially in situations where the prices of those securities were above book value before the halt. The loss of liquidity optionality from equity markets inherently increases the bankruptcy risks for any business and dealing with businesses who have lost this financing option should be strongly scrutinized. Stock Market data is one of the essential components used in the daily calculation of the FRISK®. The omission of this data can reduce the score's effectiveness in predicting bankruptcy risk for companies trading within these markets. In addition, any analysis based on previously reported financials should be used with caution in this environment. We are continuing to monitor the Russia-Ukraine conflict and plan to reevaluate the appropriateness of the FRISK® when the affected exchanges have reopened and trading in securities resumes.

Business Summary

Organika AO (Organica OJSC) is a Russia-based company engaged in the pharmaceuticals industry. The Company is involved in the production and distribution of medical drugs, medical substances, such as antibiotics, anesthetics, cardia-vasculars, hypnotics, vitamins, anxiolitics and neuraleptics, among other pharmaceutical products. The Company operates through a representative office and a wholly owned subsidiary TD Organika OOO located in Moscow. Organika AO distributes products on the domestic market, as well as exports to the Commonwealth of Independent States (CIS).

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2833	Medicinal chemicals and botanical products

Officers and Directors

Title	Name	Age	Start Date
Chairman of the Board, Advisor	Anatoly E.Vinogradov	48
General Director (CEO), Director	Andrey P.Lyangus	58	1/1/2008
Director, Technical Director	Fedor V.Guss	72	1/1/2001
5 additional Officers and Directors records available in full report.

General Information

Number of Employees:	957	(As of 12/31/2023)
Outstanding Shares:	149,852	(As of 12/31/2023)
Shareholders:	504
Stock Exchange:	RTB
Fax Number:	+7 3843994200

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN